Combined chemoradiotherapy is standard of care for advanced cervical cancer.
Chemoradiotherapy introduces DNA damage in tumor cells to induce cell death.
Tumor cells activate the ‘DNA damage response’ to repair therapy-induced DNA damage.
HPV partially impairs the cellular response to DNA damage in cervical cancer cells.
Therapeutic targeting of residual DDR could improve cervical cancer treatment.